Mixed Messaging from DOJ at HCCA Conference for Second Straight Year

Federal officials seem wary about their words and their dissemination.

At the Health Care Compliance Association’s (HCCA’s) fourth annual Healthcare Enforcement Compliance Conference, top U.S. Department of Justice (DOJ) officials provided an update on current developments related to criminal and civil fraud investigations. 

While a future article will focus on some of the highlights, this article will focus on process, because before making any remarks, the first official to speak indicated that their comments were “not for attribution.” The official then expressed concern about how comments by DOJ officials at last year’s conference were reported to the public “before lunch” on the day they were made. The DOJ seemed to be expressing a concern that it considered it to be inappropriate for comments made by the DOJ at the HCCA conference to be reported publicly.

Here is a recap of what occurred last year. While the official did not mention Monitor Mondays and RACmonitor by name, it was a story broadcast on Monitor Mondays and published in RACmonitor that seemed to trigger the concern. At that time, an official explained that the DOJ would consider moving to dismiss False Claims Act cases if the government determined that the complaint was meritless. After the RACmonitor article was published, the DOJ press office asked for a correction, because the statements at the conference were not an official policy statement, and it was asserted that there had been no change in DOJ policy, because the DOJ was always willing to intervene to dismiss meritless claims.

Then, in January 2018, a memo by Michael Granston, director of the Commercial Litigation Branch of the Fraud Section in the Civil Division of the U.S. Department of Justice, became public. That memo described the policy outlined at the conference.

So, what is the DOJ’s position on reporting on the events of the conference? And should attendees of the conference respect that position? Let’s examine both of those questions. First, the way the DOJ’s position was described was that the comments were “not for attribution.” At the conference, I asked for clarification, noting that the conference is a public forum, and presumably, the reason DOJ officials were generously providing their time by speaking was to provide guidance to both the public and industry. Unless attendees are able to recount what occurs at the meeting, it would be impossible to disseminate this important and useful information. The response was that the Department expected the information to be disseminated, but that it wasn’t “official” and, again, “wasn’t for attribution.”

Personally, I am very grateful that the DOJ officials are willing to come present at conferences. These professionals are quite busy, and they certainly are not obligated to take time out of their day to participate. I don’t want to do anything that would result in the officials refusing to attend this conference or other public gatherings. But I am also shocked at the idea that there would be any attempt to limit the dissemination of what is said at the meeting. People who are not sitting in the room are entitled to exactly the same information that attendees received, aren’t they? Statements by the DOJ at a public gathering should be public. It shouldn’t be possible for certain groups to have inside access to information from the DOJ. 

I have received two different comments about the DOJ position. I have been told both that statements made by officials at the conference should be described as “a statement by a DOJ official” without naming that official, and that the statements should be reported by naming the particular official, but emphasizing that their remarks were made in that person’s individual capacity, so it should be attributed to the person with a caveat that the statement is not an official policy position of the DOJ. We have asked the DOJ press office for clarification on their position and offered to accept comments on this article. That request was made Tuesday evening, Nov. 6, right before the President demanded the Attorney General’s resignation. So it is understandable that the office may not have had time to focus on this issue. My hope is that when I do hear from the DOJ, the clarification will be “we encourage you to report on the statements at the conference, but ask that you note in the article that statements at the conference are not official policy pronouncements.” That is, of course, true. 

Regardless of the DOJ’s position, in a free an open society, it is important to be able to report on statements made by government officials. While it is reasonable for such officials to be able to make comments to reporters off the record, when they are made in a public forum, it is difficult to see a rationale for agreeing to keep them off the record. As a result, we intend to continue reporting on the statements made at conferences.

 

Comment on this article 

Facebook
Twitter
LinkedIn

David M. Glaser, Esq.

David M. Glaser is a shareholder in Fredrikson & Byron's Health Law Group. David assists clinics, hospitals, and other health care entities negotiate the maze of healthcare regulations, providing advice about risk management, reimbursement, and business planning issues. He has considerable experience in healthcare regulation and litigation, including compliance, criminal and civil fraud investigations, and reimbursement disputes. David's goal is to explain the government's enforcement position, and to analyze whether this position is supported by the law or represents government overreaching. David is a member of the RACmonitor editorial board and is a popular guest on Monitor Mondays.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

AI, Audits, and the Future of the Revenue Cycle

Artificial intelligence is rapidly transforming healthcare revenue cycle operations, from coding and auditing to compliance and denials. Join industry leaders Pam Warren (MaineHealth) and Raemarie Jimenez (AAPC) for a live fireside chat exploring how AI is changing workflows, workforce roles, payer-provider dynamics, and compliance risk—and what organizations should be doing now to prepare.

June 17, 2026

Trending News

Featured Webcasts

Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules – Part 2

Medicare regulations are complex and even seasoned professionals struggle to apply them consistently. Due to overwhelming demand, Dr. Hirsch returns for Part 2 of Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules to answer even more of Medicare’s most misunderstood questions, covering inpatient status, observation, SNF access, Medicare Advantage denials, and more. Join Dr. Hirsch as he provides clear, referenced answers to real-world questions submitted by your peers, helping you navigate Medicare compliance with confidence and clarity.

June 18, 2026

Reengineering Utilization Management: Building an Adaptive Model for the New Payer Era

Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.

May 20, 2026

Compliance for the Inpatient Psychiatric Facility (IPF-PPS): Minimizing Federal Audit Findings by Strengthening Best Practices

Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.

April 9, 2026

Mastering MDM for Accurate Professional Fee Coding

In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.

March 31, 2026

Trending News

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

Have a Medicare regulation question you’d love Dr. Hirsch to answer? Now is your chance! CLICK HERE to learn more→

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24